Ectopic Cushing's syndrome due to concurrent corticotropin-releasing hormone (CRH) and adrenocorticotropic hormone (ACTH) secreted by malignant gastrinoma

被引:15
作者
Park, S. Y.
Rhee, Y.
Youn, J. C.
Park, Y. N.
Lee, S.
Kim, D. M.
Song, S. Y.
Lim, S. -K.
机构
[1] Yonsei Univ, Coll Med, Dept Internal Med, Div Endocrinol, Seoul 120752, South Korea
[2] Yonsei Univ, Coll Med, Endocrine Res Inst, Seoul 120752, South Korea
[3] Yonsei Univ, Div Endocrinol, Coll Med, Dept Pathol, Seoul 120749, South Korea
[4] Yonsei Univ, Coll Med, Dept Internal Med, Div Gastroenterol, Seoul 120752, South Korea
关键词
ectopic Cushing's syndrome; corticotropin-releasing hormone; adrenocorticotropic hormone; gastrinoma;
D O I
10.1055/s-2007-948212
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ectopic Cushing's syndrome due to various malignancies is not uncommon. However, a few cases of ectopic Cushing's syndrome caused by corticotropin-releasing hormone (CRH), or CRH with adrenocorticotropic hormone (ACTH) have been reported. A 28-year-old woman presented with acute upper gastrointestinal bleeding caused by an active ulcer, located atypically in the 2(nd) portion of duodenum. Further work-up revealed high gastrin levels and abdominal computed tomography (CT) scans showed a large pancreatic head mass with multiple liver metastases. The serum cortisol and ACTH levels were checked due to hypokalemia with metabolic alkalosis and recent amenorrhea. Cortisol and ACTH were both highly elevated with pituitary hyperplasia and elevated CRH. The existence of ectopic ACTH and CRH in the liver biopsy was also demonstrated immunohistochemically. Since an operation was not feasible, chemotherapy was conducted using paclitaxel and etoposide. These two drugs were chosen according to the in vitro chemotherapy response assay to maximize the treatment. This report demonstrates concurrent ACTH- and CRH-related ectopic Cushing's syndrome caused by malignant gastrinoma with multiple liver metastases that was treated with marginal success using a multidisciplinary medical approach.
引用
收藏
页码:13 / 16
页数:4
相关论文
共 25 条
[1]   Considerations concerning a tailored, individualized therapeutic management of patients with (neuro)endocrine tumours of the gastrointestinal tract and pancreas [J].
de Herder, WW ;
Krenning, EP ;
van Eijck, CHJ ;
Lamberts, SWJ .
ENDOCRINE-RELATED CANCER, 2004, 11 (01) :19-34
[2]   High-dose treatment with lanreotide of patients with advanced neuroendocrine gastrointestinal tumors: Clinical and biological effects [J].
Eriksson, B ;
Renstrup, J ;
Imam, H ;
Oberg, K .
ANNALS OF ONCOLOGY, 1997, 8 (10) :1041-1044
[3]  
Faiss S, 1996, Recent Results Cancer Res, V142, P193
[4]   Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors -: The International Lanreotide and Interferon Alfa Study Group [J].
Faiss, S ;
Pape, UF ;
Böhmig, M ;
Dörffel, Y ;
Mansmann, U ;
Golder, W ;
Riecken, EO ;
Wiedenmann, B .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (14) :2689-2696
[5]   DIAGNOSIS AND MANAGEMENT OF ACTH-DEPENDENT CUSHINGS-SYNDROME - COMPARISON OF THE FEATURES IN ECTOPIC AND PITUITARY ACTH PRODUCTION [J].
HOWLETT, TA ;
DRURY, PL ;
PERRY, L ;
DONIACH, I ;
REES, LH ;
BESSER, GM .
CLINICAL ENDOCRINOLOGY, 1986, 24 (06) :699-713
[6]  
Kurbacher CA, 2005, METH MOLEC MED, V110, P101
[7]   A ROLE OF (LABELED) SOMATOSTATIN ANALOGS IN THE DIFFERENTIAL-DIAGNOSIS AND TREATMENT OF CUSHINGS-SYNDROME [J].
LAMBERTS, SWJ ;
DEHERDER, WW ;
KRENNING, EP ;
REUBI, JC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (01) :17-19
[8]   Drug therapy - Octreotide [J].
Lamberts, SWJ ;
vanderLely, AJ ;
deHerder, WW ;
Hofland, LJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (04) :246-254
[9]   CUSHINGS-SYNDROME IN PATIENTS WITH THE ZOLLINGER-ELLISON SYNDROME [J].
MATON, PN ;
GARDNER, JD ;
JENSEN, RT .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (01) :1-5
[10]   Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin [J].
Mitry, E ;
Baudin, E ;
Ducreux, M ;
Sabourin, JC ;
Rufié, P ;
Aparicio, T ;
Lasser, P ;
Elias, D ;
Duvillard, P ;
Schlumberger, M ;
Rougier, P .
BRITISH JOURNAL OF CANCER, 1999, 81 (08) :1351-1355